Cargando…
The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey
INTRODUCTION: Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affecte...
Autores principales: | Di Noia, Vincenzo, Renna, Davide, Barberi, Vittoria, Di Civita, Mattia, Riva, Federica, Costantini, Giulia, Aquila, Emanuela Dell’, Russillo, Michelangelo, Bracco, Domenico, La Malfa, Antonia Marina, Giannarelli, Diana, Cognetti, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149194/ https://www.ncbi.nlm.nih.gov/pubmed/34183225 http://dx.doi.org/10.1016/j.ejca.2021.05.006 |
Ejemplares similares
-
Reply to the letter entitled: Re: The first report on Covid-19 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey
por: Di Noia, Vincenzo, et al.
Publicado: (2021) -
Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer
por: Di Noia, V., et al.
Publicado: (2022) -
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy
por: Fabi, Alessandra, et al.
Publicado: (2012) -
Socioeconomic Determinants in Vaccine Hesitancy and Vaccine Refusal in Italy
por: Bertoncello, Chiara, et al.
Publicado: (2020) -
Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?
por: Stagno, Anna, et al.
Publicado: (2021)